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In addition to the classical role in the homeostasis of calcium and phosphorus, 
vitamin D shows a regulatory effect on a number of different cells, especially its anti-
proliferative and pro-differential biological function. Through its own receptor in the 
immune cells, vitamin D increases the phagocytic activity of macrophages and NK cells. 
Also, by binding to the regulatory sequences of antimicrobial peptides genes, vitamin D 
increases the microbicidal activity of phagocytes. Inhibition of differentiation and 
maturation of antigen-presenting dendritic cells, as well as direct influence on their 
contact with T lymphocytes, it significantlly influences the type of immune response. 
Dendritic cells under the influence of vitamin D induce a suppressor T cells, which can 
inhibit Th1 cell response and are critical in the regulation of immune tolerance. Vitamin 
D inhibits proliferation of Th1 and Th17 cells, as well their cytokine production, and 
suppresses the differentiation and maturation of B lymphocytes. 
  Due to all these functions, vitamin D has shown beneficial effects in the 
prevention and modification of a number of autoimmune diseases. On the other hand, 
immunity disorders with predominant Th2 response (asthma, allergies) did not show 
such good results after the use of hypocalcemic VDR agonists. Acta Medica Medianae 
2012;51(4):58-64. 
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Introduction 
 
  Following exposure to sunlight, vitamin D is 
synthesized in the skin from its precursor 7-
dehydrocholesterol. Primarily created cholecalci-
ferol goes through two conversions, a 25-
hydroxylates in the liver (CYP27A1 enzyme) and 
1α-hydroxylates in the kidneys’ mitochondrial 
cytochrome P450 (CYP27B1), before it becomes a 
hormonally active form - calcitriol (1α,25-dihydroxy-
vitamin D3, 1.25(OH)2D3) (1,2). Vitamin D exerts 
its effects by binding to its own receptor (vitamin 
D receptor - VDR), a member of the nuclear 
receptor superfamily of steroid hormone or ligand-
activating transcription factor. Nuclear receptors 
act as ligand-inducible transcription factors that 
directly interact as monomers, homodimers or 
heterodimers with the retinoid X receptor (RXR). 
Vitamin D-VDR complex with RXR heterodimerises 
and initiates a cascade of macromolecular inter-
actions, through the strong affinity association 
with the vitamin D responsive elements (VDREs) 
in the promoters of the target genes. Vitamin D 
induces expression of the gene encoding D-24-
hydroxylase (CYP24A1), an enzyme that performs 
its own signal loss and degradation of vitamin D in 
the cell (3,4). 
  The most familiar, classic role of vitamin D is 
to maintain calcium and phosphorus homeostasis 
through effects on the intestine, kidney, and bone, 
in conjunction with parathyroid hormone. It stimu-
lates the differentiation of osteoblasts and depo-
sition of calcified matrix, while in the case of 
hypocalcemia it stimulates the mobilization of 
calcium from bone, promoting the differentiation 
of osteoclast precursors. The physiological function 
of vitamin D in the CNS, heart, pancreas, 
mammary gland, skin and immune system are still 
poorly understood, but it can be said that its 
overall biological function is antiproliferative and 
pro-differential (2,5). 
  The potential role of vitamin D in the 
immune system is proposed after the discovery of 
VDR in macrophages, dendritic cells and activated 
T and B lymphocytes, and the ability of these cells 
to express CYP27B1. However, it is still unclear 
whether increasing the level of vitamin D in the 
circulation has an effect on the local, paracrine 
function (6,7). Also, despite the optimal level of 
vitamin D in circulation, the metabolism capacity 
can vary among individuals, as proposed in the 
case of certain genetic polymorphisms in VDR and 
vitamin D metabolizing enzymes. Four poly-
morphisms (FokI T_C, BsmI A_G, ApaI G_T and 
T a q I  C _ T )  o f  V D R  g e n e  h a v e  b e e n  e x t e n s i v e l y  
studied in order to find their association with 
various diseases, including tumors of different Acta Medica Medianae 2012, Vol.51(4)                                                                                  Vitamin D immunomodulatory effect 
localization, as well as diseases associated with 
disorders of the immune response (8). 
 
  Vitamin D role in innate immune 
response 
 
  The current researches show that an 
important component of the monocyte-macro-
phage response to infection is intracrine induction 
of the antimicrobial activity of vitamin D (9). 
Activity of natural killer cells (NK) and phagocytic 
activity of macrophages is increased after the use 
of VDR ligands. However, at the same time, the 
stimulatory capacity of monocytes and macro-
phages is reduced, as determined by reduction of 
surface expression of MHC-II and co-stimulatory 
molecules (CD40, CD80 and CD86) (10). Differen-
tiation of monocytes was accompanied by reduced 
expression of VDR, which makes the mature 
forms of these cells less sensitive to vitamin D 
(11). In contrast, the expression of VDR is 
prominent in activated T lymphocytes, whereas it 
is very weak in naive T cells (12). In dendritic 
cells, the levels of CYP27B1 are increased during 
the cell maturation (13), while in T and B 
lymphocytes the expression of these enzymes 
increases dramatically after their activation 
(Figure 1) (14). 
  Immunomodulatory effects of vitamin D 
occurs through the regulation of nuclear trans-
cription factors, NF-AT and NF-kappaB, or direct 
binding to the vitamin D responsive elements in 
the promoters of cytokines’ genes (15). Vitamin 
D inhibits the expression of interferon and 
proinflammatory cytokines in monocytes (IL-1, 
IL-6, TNF-α, IL-8 and IL-12) (16). The gene for 
TNF-α has VDR responsive elements in its 
promoter, while the gene for IFN-γ has a 
negative transcriptional regulatory elements for 
vitamin D. The regulation of granulocyte-macro-
phage colony stimulating factor is regulated by 
VDR monomers, which bind to the repressive 
complex in the promoter of this gene, competing 
with the nuclear factor AT1. Vitamin D blocks the 
activation of NF-kB by increasing the expression 
of IκBα and interfering with binding of NF-kB to 
the genes it regulates (IL-8, IL-12, etc.) (17). 
  The effect of vitamin D has been parti-
cularly investigated on the maturation, differen-
tiation and migration of antigen presenting 
dendritic cells (DC). Vitamin D and its analogues 
inhibit the differentiation and maturation of DC, 
although these cells alone express CYP27A1 and 
are capable of creating 25OH-vitamin D. In vitro 
treatment of DC with calcitriol leads to down-
regulation of CD40, CD80 and CD86 co-stimula-
tory molecules expression and decreased produ-
ction of IL-12, while IL-10 production is 
increased. This contributes to the reduction of T 
cell activation level, in other words, vitamin D 
acts in creating a tolerogenic type of DCs (6,18,19). 
  It has been shown that the addition of 
calcitriol to the monocyte cell culture, on the first 
day, blocks DC differentiation from monocytes 
and inhibits the appearance of the characteristic 
cell surface molecules CD1a+, while increases 
the expression of monocyte-macrophage marker 
CD14+. Calcitriol treatment during DC maturation 
leads to the loss of CD1a marker and clear 
reinduction of CD14. In contrast, mature DC were 
CD1a+CD14- after addition of calcitriol. Obvious 
suppression of DC differentiation and phenotype 
inversion of immature DC may explain some of the 
immunosuppressive properties of vitamin D. 
Contrary to the anti-proliferative effects of 
vitamin D on some cell types, DC formation in 
the bone marrow is not suppressed. It is also 
significant that DC treated with vitamin D 
analogues have not progressed to a higher level 
of maturation after the end of the treatment, and 
that they clearly expressed weakened response 
to maturation signals (19). 
 
 
Figure 1. Immunomodulatory effect of 1,25(OH)2D3 
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  Protein profile in the DC changes significantly 
when exposed to VDR agonists. Major changes 
were observed in proteins involved in protein 
biosynthesis/proteolysis and cytoskeletal structure, 
which may have an impact on the formation of 
DC - T cell contacts and thereby T cells acti-
vation. Vitamin D also has the potential 
modulatory role in the binding of antigen to DC in 
the initiation phase of immune response. It 
enhances expression of mannose receptors, 
molecules involved in antigen binding, which 
correlates with higher endocytic capacity (20,21). 
  The vitamin D active form increases the 
expression of different endogenous antimicrobial 
peptides, with a broad spectrum of activity against 
bacteria, fungi and viruses (22). In response to innate 
immunity, the activation of Toll-like receptor (TLR) 
ligands results in direct antimicrobial response by 
polymorphonuclear cells, monocytes and macro-
phages. The resulting immune response consists in 
the production of reactive oxygen species and 
antimicrobial peptides, such as cathelicidins. Gene 
promoter of the human antimicrobial peptide 
cathelicidins contains functional vitamin D responsive 
elements (10). It has been shown that vitamin D 
treatment of human keratinocytes, monocytes and 
neutrophils induces the transcription of this peptide. 
Toll-like receptor-mediated up-regulation of VDR 
and CYP27B1 expression causes an intracrine, 
vitamin D-dependent, induction of cathelicidins 
and increased microbicidal activity of macro-
phages. Cathelicidin further stimulates the release 
of IL-6, IL-10, IL-18, expression of epidermal 
growth factor receptor, induces chemotaxis of 
neutrophils, monocytes, macrophages, T cells, 
and starts the proliferation and migration of 
keratinocytes (21). The above results show the 
importance of extra-renal expression of 1-α-
hydroxylase (CYP27B1) in the vitamin D-mediated 
innate immunity. Extra-renal CYP27B1 enzyme is 
completely under the different type of control in 
comparison to the renal form of the enzyme, it is 
not influenced by parathyroid hormone, but can 
be stimulated by cytokines (1,6,11). CYP27B1 
expression and production of calcitriol in mono-
cytes-macrophages was strongly stimulated by 
IFN-γ, TNF-α, IL-1 and IL-2 (14), TLR4-ligand 
lipopolysaccharide and ligands that act on TLR2/1 
complex (19kD mycobacterium tuberculosis lipo-
protein and viral infection). However, no clear 
negative feedback was found between these 
factors and vitamin D. Activated macrophages 
are able to produce calcitriol, sometimes leading 
to hypercalcemia, as in situations with macro-
phage hyperactivation, as in sarcoidosis (12).  
  Since the mid 19
th century, it is well known that 
vitamin D induces antimycobacterial activity of 
monocytes and macrophages, and reduces the 
production of proinflammatory cytokines, which is 
important in the treatment of tuberculosis and leprosy 
(12). The mechanism of its effect on tuberculosis was 
unknown to the research conducted by Liu et al.   
(23), who noted that activation of TLR2/1 via 
lipoproteins extracted from M. tuberculosis 
reduced the viability of intracellular mycobacteria 
in human monocytes and macrophages, along 
with increased expression of VDR and CYP27B1. 
Efficient elimination of mycobacteria existed only 
in the presence of adequate levels of 25-hydroxy 
vitamin D, the substrate of the enzyme CYP27B1. 
This demonstrated the key role of endogenous 
production of active vitamin D in antimyco-
bacterial capacity of macrophages. Formation of 
cathelicidins in macrophages also helps in the 
fight against mycobacteria. Vitamin D is able to 
induce autophagy and mediates the co-loca-
lization of mycobacteria and antimicrobial 
peptides within autophagosomes, accelerating 
the destruction of bacteria. It is significant that 
this hormone also inhibits TLR2 and TLR4 
expression on monocytes, inducing condition of 
hyporesponsiveness to pathogen-associated mole-
cular pattern (PAMPs) (24). This effect is mostly 
expressed after 72 hours and was nominated for 
a negative feedback mechanism that prevents 
excessive TLR activation and inflammation in the 
late infection phase. At the same time, vitamin D 
significantly reduces mycobacterial-induced expression 
of matrix metalloproteinases in monocytes. 
Metalloproteinases can degrade all components 
of pulmonary extracellular matrix and is thought 
to participate in the pathogenesis of pulmonary 
tuberculosis cavitation. In activated monocytes, 
vitamin D stimulates the secretion of IL-10 and 
prostaglandin E2, transcription regulator that 
suppresses the expression and secretion of 
metalloproteinases (25). 
  The recent studies have indicated that the 
antimicrobial vitamin D activity is VDR- mediated 
and accompanied with the strong induction of 
antimicrobial peptides, cathelicidins and defen-
sins b2, in various cells, including myeloid cells, 
keratinocytes, neutrophils, and bronchial epithelial 
cells (24). The epithelium is a key factor in the 
innate immune response initiation. It contains the 
largest number of cells that express CYP27B1, 
and it is believed that UVB radiation is sufficient 
to create the active form of vitamin D in them. 
Keratinocytes express CYP24A1 and thus regulate 
the concentration of 1,25(OH)2D3 (26), so they 
can modulate the immune response. It has been 
shown that keratinocytes treated with calcitriol 
are significantly more effective in killing Staphylo-
coccus aureus (27).  
 
  Vitamin D role in adaptive immune 
response 
 
  Immunomodulatory effects of vitamin D in the 
acquired immune system are the result of its direct 
effect on cell proliferation, differentiation and 
apoptosis of T lymphocytes (especially T-helper) and 
B-lymphocytes (16). Vitamin D inhibits proliferation 
and cytokine response of Th1 and Th17 cells, induces 
the formation of regulatory T-cells (Treg or Th3) and 
the production of IL-4. Differentiation and maturation 
of B cells is inhibited by the use of 1,25(OH)2D3 (15). 
Also, by slowing the maturation of DC and inhibiting Acta Medica Medianae 2012, Vol.51(4)                                                                                  Vitamin D immunomodulatory effect 
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the expression of MHC II molecules and co-
stimulating molecules on antigen presenting cells, 
vitamin D reduces the ability of these cells to present 
antigens and activate T cells (10). In addition, vitamin 
D modulates the expression of cytokines in DC, 
inhibiting the production of key cytokines of Th1 and 
Th17 differentiation (IL-12 and IL-23), but enhancing 
the release of IL-10, and chemokines MIP-3a (CCL22) 
involved in the recruitment of regulatory CCR4+ T 
cells (11, 28). 
  Overall, vitamin D exerts an inhibitory effect on 
the acquired immune system. By suppression of IL-12 
production, an important factor for T-helper cells 
development, it inhibits the development of Th1 cells, 
and thus the production of IFN-γ and IL-2. Also, by 
reduced secretion of IL-23 and IL-6, vitamin D inhibits 
Th17 development and function of these cells, as well 
the secretion of Th17 cytokines, IL-17 and IL-21. 
Decrease in IFN-γ reduces the recruitment of T cells, 
and a decrease of IL-2 reduces their proliferation. At 
the same time, suppression of IL-12 promotes the 
development of Th2 cells, which leads to increased 
production of IL-4, IL-5 and IL-10, which further 
suppresses Th1 cells, and shifts the balance towards 
Th2 phenotype (7, 29). 
  Treatment of dendritic cells with vitamin D may 
induce a formation of CD4+/CD25+ suppressor T 
cells, due to reduced expression of co-stimulatory 
molecules and production of IL-10. These cells inhibit 
Th1 cell responses and are critical in the regulation of 
immune tolerance. Ability of VDR agonists to enhance 
Treg activation in vitro was observed in a number of 
studies. In addition, VDR agonists enhance the 
suppressive capacity of Treg cells (30). It has been 
shown that vitamin D regulates a set of genes in the 
DC cells, which increases the potential of these cells to 
induce Treg cells, independently of vitamin D effect on 
DC differentiation and maturation. However, the role 
of tolerogenic DC does not seem to prerequisite the 
Treg cells induction with vitamin D, as evidenced by 
the very action of vitamin D, or in combination with 
dexamethasone, for the creation of IL-10 producing 
Treg cells in in vitro system, in the absence of antigen 
presenting cells (31). 
  VDR expression dramatically increases in T 
lymphocytes following their activation. High VDR 
expression can be induced by various T cell activation 
stimuli, such as anti-CD3/anti-CD28, creating two 
necessary activation signals. The expression level and 
dynamics depend on the stimulus, so that the 
different effects of vitamin D on T cells can be 
registered (12,28,31). 
  Direct effects of vitamin D on the production of 
Th2 cytokines are currently less well known. 
According to some studies, vitamin D potentiates the 
formation of Th2 cells with up-regulation of specific 
transcription factor GATA-3 and c-maf expression, 
and associated cytokines (IL-4), while other studies 
contraindicated these findings (32,33). T cells of VDR 
knock-out (KO) mice produced more IFN-γ and less 
Th2 cytokines (IL-4 and IL-5) compared to T cell of 
normal animal type (wild type - WT) (34). 
  Influence of vitamin D on B cells is less known. 
Although the modulation of Th responses inevitably 
affects a B cell compartment, these cells are also 
directly affected by vitamin D. Exposure of B cells to 
the active form of the vitamin inhibits their 
proliferation, plasma cell differentiation and secretion 
of immunoglobulins (IgG, IgM and IgE), the creation 
of memory B cells, and induces B cell apoptosis (7). 
The downside of acquired immunity suppression is 
susceptibility to development of a number of 
infections. In an experimental model of mice has been 
shown that 1,25(OH)2D3 predisposes infection with 
Leishmania maior and toxoplasmosis, while VDR-null 
mice were relatively protected (8). This is partly 
explained by the reduction of IFN-γ, which is required 
for the stimulation of macrophages and production of 
reactive oxygen species and NO. 
 
  Effect of vitamin D on autoimmune 
diseases 
 
  Although there is still no large-scale prospective 
studies, the results of epidemiological studies suggest 
an association between a number of diseases with a 
concentration of vitamin D in the blood (7). Due to the 
ability to induce innate and suppress acquired 
immune response, vitamin D has a beneficial role in 
the prevention and treatment of various autoimmune 
diseases, and the prevention of transplant rejection 
(6, 28). There is an inverse correlation between 
serum vitamin D concentration and the incidence and 
severity of autoimmune diseases, such as type 1 
diabetes mellitus (DM), systemic lupus erythe-
matosus, multiple sclerosis (MS), inflammatory bowel 
disease (IBD), rheumatoid arthritis, psoriasis, 
fibromyalgia and other (12,18,35). In contrast, 
vitamin D does not exhibit the same beneficial effects 
in a number of diseases in which the immune system 
plays a key role, such as asthma and infection. Some 
authors draw attention to vitamin D enriched foods, 
which seems to cause a higher incidence of allergic 
diseases (28). In the study of Hypponen et al. (36), 
the prevalence of atopy, allergic rhinitis and asthma 
was higher in people who were regularly taking 
vitamin D supplements during the first year of life. 
  Examples of Th1 autoimmune diseases are MS, 
type 1 DM and IBD, while allergy and asthma are 
influenced by Th2 lymphocytes (28). In various 
experimental models (inflammatory arthritis, 
autoimmune diabetes, tieroidits) VDR agonist 
administration prevented and/or attenuated the 
disease, through the inhibition of Th1 response. It was 
found that children with vitamin D deficiency have a 
higher risk of type 1 diabetes development, and 
vitamin D supplementation in infancy reduced the 
development of this disease (29). Similarly, diseases 
and conditions with active Th17 immune response 
(arthritis, psoriasis, experimental allergic encephalitis) 
respond positively to VDR agonist treatment. The 
active form of vitamin D has a direct repressive effect 
on the transcription of IL-17 in T cells (37). 
  The prevalence of MS is highest in countries 
where sun exposure is lowest, and vice versa. Also, 
the incidence of MS is higher in people who have low 
levels of 25-OH-vitamin D in the blood. It is believed 
that the mechanism of vitamin D effects on MS is Vitamin D immunomodulatory effect                                                                                                            Jelena Radović et al. 
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associated with paracrine and autocrine 25-OH-
vitamin D metabolism in immune and nerve cells, 
which express CYP27B1. It has been shown that 
vitamin D treatment of experimental autoimmune 
encephalomyelitis (a mouse model of MS) eliminated 
paralyses and disease progression, with a clear 
reduction in the number of Th17 cells (37). 
  Vitamin D deficiency is often seen in Crohn 
disease (38). In an animal model of enterocolitis, IL-
10 knock-out mice develop disease within 9-12 weeks 
of age. Vitamin D deficiency in these mice accelerated 
the development of IBD symptoms, while vitamin D 
deficit delayed the disease onset. Mice negative for 
VDR and IL-10 developed severe colitis. It was also 
noted that the presence of calcium in the diet further 
affects the efficiency of vitamin D treatment in IBD. 
Such treatment of KO mice reduced the number of 
lymphocytes in the lymph nodes, and increased levels 
of IL-4 and TGF-ß1 transcription (18). 
  Th2 cells play a dominant role in the 
inflammatory response in allergic respiratory diseases. 
In animal allergic asthma model, the development of 
the disease was examined in VDR KO, WT or WT 
mice, treated with active vitamin D. Asthma 
developed in WT mice, in contrast to the VDR KO 
mice, despite the formation of antigen-specific 
Th2 cell responses in the periphery and high 
concentrations of IgE (39). Vitamin D treatment in WT 
mice did not affect the severity of the disease, 
although in a similar study of Th2 dependent animal 
model of asthma, the active form of vitamin D had 
anti-inflammatory effects (40). Also, when VDR KO 
splenocytes were transferred into WT mice they were 
able to cause bronchial inflammation in WT mice, 
while in the opposite case the disease did not develop. 
Presently, there is no clear explanation of these 
results. It is assumed that Th2 cells do not infiltrate 
the lungs at all, or that VDR KO mice epithelial cells 
are unable to respond to inflammation by the 
experiment. 
  The positive effects of VDR agonists in 
combination with immunosuppressive agents have  
 
been observed in transplant procedures, which require 
the inhibition of the acquired immune response. In an 
experimental model of aortic allograft, bone, bone 
marrow, heart, kidney, liver, pancreatic islets, skin 
and small intestine, VDR agonists had a beneficial 
effect (30). Favorable effects consisted in reduced 
infiltration of Th1 cells, macrophages and dendritic 
cells in the graft tissue, decreasing the production of 
Th1 cytokines. 
  Unfortunately, the clinical applications of 
vitamin D for the modulation of immune responses 
are limited by its toxicity, especially hypercalcemic 
side effects. There is also a problem with hyper-
calcemia, in some diseases with immune system 
disorders, due to elevated values of active vitamin 
D in the blood (sarcoidosis, tuberculosis, Crohn's 
disease, T cell lymphoproliferative disorders), which 
can be explained by stimulation of cytokine 
expression of CYP27B1 and CYP24A1 dysfunction. 
To overcome this limitation, VDR agonists are to be 
designed, which should not cause hypercalcemic 
effects but have an immunoregulatory activity similar 
to that of the active vitamin D (12). 
 
 Conclusion 
 
  Vitamin D can be designated as a selective 
immune system regulator and modulator of growth, 
differentiation and function of immune cells. It affects 
both types of immune response, by emphasizing the 
innate and suppressing the acquired immunity, 
contributing to immune tolerance. Vitamin D directly 
regulates the expression of antimicrobial peptides and 
improves the function of macrophages in defense 
against mycobacteria. Also, vitamin D shows a useful 
role in the prevention and treatment of various 
autoimmune diseases and the prevention of 
transplant organ rejection. Vitamin D receptor 
agonists, particularly hypocalcemic analogues, are 
eligible candidates for the prevention and treatment of 
infections and some autoimmune disorders. 
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IMUNOMODULATORNO DEJSTVO VITAMINA D 
 
Jelena Radović, Danica Marković, Asen Veličkov, Branka Đorđević i 
Slavica Stojnev 
 
 
Pored klasične uloge u homeostazi kalcijuma i fosfora, vitamin D pokazuje 
regulatorni uticaj na veći broj različitih ćelija, pre svega svojom antiproliferativnom i 
prodiferencijacionom biološkom funkcijom. Vezivanjem za sopstveni receptor u 
imunskim  ćelijama vitamin D povećava fagocitnu aktivnost makrofaga i NK ćelija. 
Takođe, vezivanjem za regulatorne sekvence gena antimikrobnih peptida, vitamin D 
povećava mikrobicidnu aktivnost fagocita. Inhibicijom diferencijacije i maturacije 
antigen prezentujućih dendritičnih ćelija, kao i direktnim uticajem na kontakt ovih ćelija 
sa T limfocitima, on značajno utiče na vrstu imunološkog odgovora. Dendritične ćelije 
pod uticajem vitamina D indukuju stvaranje supresornih T ćelija, koje mogu inhibirati 
Th1  ćelijski odgovor i kritične su u regulaciji imunološke tolerancije. Vitamin D 
suprimira proliferaciju Th1 i Th17 ćelija kao i produkciju njihovih citokina, a inhibitorno 
utiče na diferencijaciju i maturaciju B limfocita. 
 Usled navedenih funkcija, vitamin D je pokazao povoljne efekte u prevenciji i 
modifikaciji određenog broja autoimunoloških bolesti. S druge strane, poremećaji 
imuniteta sa dominantnim Th2 odgovorom (astma, alergije) nisu pokazali tako dobre 
rezultate posle primene hipokalcemičnih VDR agonista. Acta Medica Medianae 
2012;51(4):58-64. 
 
Ključne reči: vitamin D, imunomodulatorno dejstvo, urođeni imunitet, katelicidin 